during the epidemic period, the subsidy policy is mainly aimed at the medical expenses incurred by the pneumonia patients diagnosed with novel coronavirus infection. After the basic medical insurance, serious illness insurance and medical assistance are paid according to the regulations, the personal burden will be subsidized by the finance and comprehensive protection will be implemented.

Legal basis

Article 2 of the Notice of the National Health Insurance Bureau and the Ministry of Finance on Doing a Good Job in Medical Security for Pneumonia Infected in novel coronavirus

ensures that patients are not affected by the cost. First, for the medical expenses incurred by patients with pneumonia diagnosed in novel coronavirus, after the basic medical insurance, serious illness insurance and medical assistance are paid according to the regulations, the personal burden will be subsidized by the finance and comprehensive protection will be implemented. Second, for the patients who have been diagnosed with pneumonia in novel coronavirus, they should be treated first and then settled, and the reimbursement should not be reduced. Third, the drugs and medical services used by patients with pneumonia diagnosed in novel coronavirus are in line with the diagnosis and treatment plan of pneumonia infected in novel coronavirus formulated by the health department, and can be temporarily included in the scope of medical insurance fund payment.

Article 3 of the Notice of the National Health Insurance Bureau and the Ministry of Finance on Doing a Good Job in Medical Security for Pneumonia Infected in novel coronavirus

ensures that hospitals are not treated because of the payment policy. For medical institutions that treat more patients, medical insurance agencies can pay part of the funds in advance to reduce the pressure on medical institutions to pay.